- Published at
- by seekingalpha.com
positive
positive
Lots Of Bullish Signals, But No Revenue Or Earnings From Tyra Biosciences (NASDAQ:TYRA)
Tyra Biosciences is a speculative play with potential for growth despite lack of revenue, focusing on precision medicines in oncology. See why TYRA is hold rated.